# Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma

> **NCT02999711** · PHASE1 · COMPLETED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 23 (actual)

## Conditions studied

- Asthma
- Moderate Asthma

## Interventions

- **DRUG:** REGN3500
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02999711
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-03
- **Primary completion:** 2018-08-30
- **Final completion:** 2018-09-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02999711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02999711, "Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02999711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*